Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells
Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells
复制标题
DOI:
10.1016/j.yjmcc.2008.10.011
复制
发表时间:
2009-02-01
影响因子:
5
通讯作者:
Tanner, Felix C.
中科院分区:
文献类型:
--
作者:
Holy, Erik W.;Akhmedov, Alexander;Tanner, Felix C.
Berberine (BBR) is a novel natural hypolipidemic agent. This study investigates whether BBR, similar to statins, exerts pleiotropic effects on endothelial tissue factor (TF) expression. BBR enhanced tumor necrosis factor-a (TNF-alpha) and thrombin induced TF expression in human endothelial cells by 3.5-fold. These effects were paralleled by an enhanced TF surface activity. In contrast, expression of TF pathway inhibitor was impaired. BBR enhanced TNF-alpha induced TF mRNA expression; however, TF promoter activity was inhibited. Activation of ERK and p38 remained unaffected, while c-Jun terminal NH2 kinase was inhibited. BBR reduced TF mRNA degradation rates, prolonging its half-life from 1.1 to 4.3 h. The HMG-CoA reductase inhibitor simvastatin impaired thrombin induced TF expression, and BBR blunted this inhibition. Simvastatin did not affect TNF-alpha induced TF expression, and BBR enhanced TF under these conditions. Administration of BBR (100 mg/kg/d) increased TF activity and impaired TFPI expression in carotid artery of ApoE(-/-) mice. BBR enhances TF via mRNA stabilization at clinically relevant concentrations. Clinical application of BBR, either as an alternative to or in combination with statins, should be considered with caution. (C) 2008 Elsevier Inc. All rights reserved.